Pituitary Preceptorship: How do I decide when to discontinue cabergoline therapy in prolactinomas
Pituitary Preceptorship: How do I decide when to discontinue cabergoline therapy in prolactinomas
Dr. Greisa Vila
The educational content presented and discussed during the meeting are now available.
Dr. Greisa Vila
Endocrinologist
Medical University of Vienna
Austria
Expert View | 
15 min
|accreditation:
EACCME |
Nov 2021
download resources
I agree that this educational programme:
This programme is supported by an Independent Educational Grant from Ipsen
This course has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) and ECMEC® is available. Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™.
PITUITARY CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Ipsen.
Other programmes of interest
5 min
